Complex Lymphedema Therapy (Complete Decongestive Therapy) - (CPG157) | CIGNA Coverage Update

TL;DR: Cigna Healthcare modified CPG157 (cpg157_complex_lymphedema_treatment) covering complex lymphedema therapy, effective September 26, 2025. Here's what changes for billing teams.

This update to the Cigna Healthcare complex lymphedema therapy coverage policy affects how you bill HCPCS S8950 for complete decongestive therapy sessions — and it explicitly designates CPT 97016 (vasopneumatic devices) as not medically necessary for this condition. If your practice bills lymphedema therapy under Cigna, the medical necessity criteria, duration limits, and code-level coverage designations in this policy directly affect your reimbursement.

---

Quick-Reference Table

Field	Detail Copy
Payer	Cigna Healthcare
Policy	Complex Lymphedema Therapy (Complete Decongestive Therapy)
Policy Code	cpg157_complex_lymphedema_treatment
Change Type	Modified
Effective Date	2025-09-26
Impact Level	Medium
Specialties Affected	Physical therapy, occupational therapy, lymphedema rehabilitation, oncology rehab
Key Action	Remove CPT 97016 from lymphedema therapy charge capture; bill HCPCS S8950 for covered CLT sessions meeting the two-to-five times per week, two-week criteria

---

Cigna Complex Lymphedema Therapy Coverage Criteria and Medical Necessity Requirements 2025

The core of this coverage policy comes down to two factors: diagnosis and duration. Cigna considers complex lymphedema therapy (CLT) — also called complete decongestive physiotherapy (CDP) or complex decongestive therapy (CDT) — medically necessary for primary or secondary lymphedema when it's provided within a specific frequency and time window.

The approved program runs two to five sessions per week for two weeks. That's the sweet spot this coverage policy protects. Programs beyond four weeks are generally considered not medically necessary by Cigna — full stop.

Here's the structure Cigna expects:

Phase I (Treatment Phase — two to four weeks) covers four components:

Phase II (Maintenance Phase) is lifelong self-care. The patient maintains limb size through the techniques learned in Phase I: skin and nail care, wearing an elastic sleeve during the day, overnight bandaging, and exercises. Cigna does not expect ongoing in-office billing for Phase II.

The self-management piece is significant for billing teams. Cigna's policy states that most patients should be able to move to a home-based program after one to two weeks of in-office therapy. Instruction in self-management should begin in the first week. After that initial period, the patient gets re-evaluated to determine whether continued in-office treatment is necessary — or whether care moves home.

That re-evaluation checkpoint matters. If your provider continues billing in-office sessions past the two-week mark without documented clinical justification, you're looking at a claim denial risk. The policy is explicit: extended programs beyond four weeks are generally not medically necessary.

The Cigna complex lymphedema therapy coverage policy does not specifically mention prior authorization requirements within the CPG157 policy text. That said, prior auth requirements can vary by plan and contract. Check your specific Cigna plan contract before assuming these visits are pre-authorized. If you're seeing a high volume of Cigna lymphedema claims, talk to your billing consultant before September 26, 2025 to confirm whether prior authorization applies to your patient population.

For reimbursement, HCPCS S8950 bills in 15-minute increments. A standard 60-minute manual lymph drainage session would be four units. Your charge capture needs to reflect actual time spent, not a flat per-visit unit.

---

Cigna Complex Lymphedema Therapy Exclusions and Non-Covered Indications

The clearest exclusion in this policy is CPT 97016. Cigna designates the application of vasopneumatic devices (CPT 97016) as not medically necessary for complex lymphedema therapy.

This is the code that covers pneumatic compression devices applied in the clinical setting. Cigna's position is that vasopneumatic device application is not a covered component of CLT. If your therapists have been bundling CPT 97016 into lymphedema treatment visits, that practice ends with the September 26, 2025 effective date — if it wasn't already a problem before.

The real issue here is that vasopneumatic compression and manual lymph drainage are sometimes used together in practice. But Cigna draws a hard line: MLD billed through S8950 is covered when criteria are met; CPT 97016 is not covered as part of this treatment pathway.

Don't try to work around this by bundling 97016 into a different diagnosis or unlinking it from the lymphedema visit. That's a compliance problem, not a billing workaround. If your compliance officer isn't already aware of this code-level exclusion, loop them in now.

Extended treatment programs also fall outside coverage. Programs beyond four weeks are not medically necessary under this policy. If your providers document clinical necessity for longer programs, that documentation needs to be bulletproof — and you should expect those claims to face heightened scrutiny or denial.

---

Coverage Indications at a Glance

---

Cigna Complex Lymphedema Therapy Billing Guidelines and Action Items 2025

These are the steps your billing team needs to take before September 26, 2025.

1. Pull CPT 97016 from your lymphedema therapy charge capture now.

If your charge master or superbill lists CPT 97016 as an option for lymphedema treatment visits, remove it. Cigna's policy is explicit: vasopneumatic device application is not medically necessary for CLT. Any 97016 claim tied to a lymphedema visit is a claim denial waiting to happen.

2. Confirm your S8950 units match documented time.

HCPCS S8950 reimburses in 15-minute increments. Audit a sample of recent S8950 claims against your therapy notes. Four units equal 60 minutes. Mismatches between documentation and billed units are a red flag in any audit.

3. Build a duration flag into your workflow.

Create a trigger in your billing system that flags any Cigna lymphedema case approaching or exceeding four weeks of in-office treatment. The policy states programs beyond four weeks are generally not medically necessary. You need clinical documentation before billing that far — and you need to catch it before the claim goes out, not after a denial.

4. Audit your re-evaluation workflow at weeks one and two.

Cigna expects a re-evaluation after the initial one-to-two-week program. If your providers aren't documenting that re-evaluation — and the clinical rationale for continuing in-office therapy — your claims for weeks three and four are vulnerable. Make the re-evaluation note a required step in your lymphedema treatment workflow.

5. Check prior authorization requirements for your specific Cigna contracts.

The CPG157 policy text doesn't detail prior auth requirements, but that doesn't mean your plans don't require it. Review your Cigna plan contracts or call provider services to confirm PA requirements for S8950 before the September 26, 2025 effective date. If prior authorization is required and you're not getting it, you're writing off revenue.

6. Train your therapists on the self-management transition.

Billing for in-office sessions after a patient should have transitioned to a home program is a medical necessity problem, not just a billing one. Cigna's policy is clear: instruction in self-management starts in week one, and the patient should be re-evaluated for home transition after one to two weeks. If your therapists aren't documenting that conversation — and the clinical reason a patient still needs in-office care — your claims won't hold up.

7. Confirm coding for manual lymph drainage specifically.

MLD is the core covered component of CLT under S8950. Make sure your therapists' notes describe the technique, duration, and limb treated in enough detail to support the S8950 units billed. "Lymphedema treatment" without specifics doesn't support the per-unit billing structure.

---

CPT, HCPCS, and ICD-10 Codes for Complex Lymphedema Therapy Under cpg157_complex_lymphedema_treatment

The policy lists two codes. That's it. Use them correctly.

Covered HCPCS Codes (When Medical Necessity Criteria Are Met)

Code	Type	Description Copy
S8950	HCPCS	Complex lymphedema therapy, each 15 minutes

S8950 is your primary billing vehicle for in-office CLT sessions. Bill it per 15-minute increment. Document treatment components — skin and nail care, manual lymph drainage, compression bandaging, therapeutic exercise — in your therapy notes for each visit.

Not Covered Under This Policy

Code	Type	Description	Reason Copy
97016	CPT	Application of a modality to 1 or more areas; vasopneumatic devices	Considered not medically necessary for complex lymphedema therapy under CPG157

No ICD-10-CM codes are listed in the CPG157 policy data. Your diagnosis coding for primary lymphedema (Q82.0) or secondary lymphedema (I97.2, for post-mastectomy; I89.0 for other secondary) should follow your standard coding guidelines and clinical documentation. Cigna's policy doesn't restrict specific diagnosis codes, but your diagnosis must support the lymphedema indication to establish medical necessity.

---